These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1746981

  • 21. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 22. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 23. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis.
    Neal RA, Murphy AG, Olliaro P, Croft SL.
    Trans R Soc Trop Med Hyg; 1994 Jul; 88(2):223-5. PubMed ID: 8036682
    [Abstract] [Full Text] [Related]

  • 24. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A, Joseph M, Feltis T, Morris SK.
    Am J Trop Med Hyg; 2016 Oct 05; 95(4):793-794. PubMed ID: 27549634
    [Abstract] [Full Text] [Related]

  • 25. Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work.
    Polat E, Cakan H, Aslan M, Sirekbasan S, Kutlubay Z, Ipek T, Ozbilgin A.
    Exp Parasitol; 2012 Oct 05; 132(2):129-34. PubMed ID: 22750454
    [Abstract] [Full Text] [Related]

  • 26. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador.
    Krause G, Kroeger A.
    Trans R Soc Trop Med Hyg; 1994 Oct 05; 88(1):92-4. PubMed ID: 8154018
    [Abstract] [Full Text] [Related]

  • 27. Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals.
    El-On J, Jacobs GP, Witztum E, Greenblatt CL.
    Antimicrob Agents Chemother; 1984 Nov 05; 26(5):745-51. PubMed ID: 6517557
    [Abstract] [Full Text] [Related]

  • 28. The lack of effectiveness of hyperbaric oxygenation as a treatment for Leishmania major in a mouse model.
    Livneh A, Youngster I, El-On Y, Berkovitch M, Abu-Kishk I.
    Acta Parasitol; 2015 Jun 05; 60(2):345-9. PubMed ID: 26204005
    [Abstract] [Full Text] [Related]

  • 29. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2.
    Zur E.
    Int J Pharm Compd; 2019 Jun 05; 23(4):288-293. PubMed ID: 31315079
    [Abstract] [Full Text] [Related]

  • 30. Protection of guinea pigs against cutaneous leishmaniasis by combined infection and chemotherapy.
    El-On J, Witztum A, Schnur LF.
    Infect Immun; 1986 Feb 05; 51(2):704-6. PubMed ID: 3943909
    [Abstract] [Full Text] [Related]

  • 31. Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.
    Kim DH, Chung HJ, Bleys J, Ghohestani RF.
    PLoS Negl Trop Dis; 2009 Feb 05; 3(2):e381. PubMed ID: 19221595
    [Abstract] [Full Text] [Related]

  • 32. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV, Fernandes AP, Ferreira LA.
    Parasitol Res; 2007 May 05; 100(6):1221-6. PubMed ID: 17206508
    [Abstract] [Full Text] [Related]

  • 33. Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice.
    Jaafari MR, Bavarsad N, Bazzaz BS, Samiei A, Soroush D, Ghorbani S, Heravi MM, Khamesipour A.
    Antimicrob Agents Chemother; 2009 Jun 05; 53(6):2259-65. PubMed ID: 19223613
    [Abstract] [Full Text] [Related]

  • 34. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
    Stanimirović A, Stipić T, Skerlev M, Basta-Juzbasić A.
    J Eur Acad Dermatol Venereol; 1999 Nov 05; 13(3):214-7. PubMed ID: 10642059
    [Abstract] [Full Text] [Related]

  • 35. Topical treatment of cutaneous leishmaniasis.
    el-On J, Livshin R, Paz ZE, Weinrauch L.
    Br Med J (Clin Res Ed); 1985 Nov 02; 291(6504):1280-1. PubMed ID: 3933633
    [No Abstract] [Full Text] [Related]

  • 36. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
    Bavarsad N, Fazly Bazzaz BS, Khamesipour A, Jaafari MR.
    Acta Trop; 2012 Oct 02; 124(1):33-41. PubMed ID: 22750480
    [Abstract] [Full Text] [Related]

  • 37. Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice model.
    Heidari-Kharaji M, Taheri T, Doroud D, Habibzadeh S, Rafati S.
    Appl Microbiol Biotechnol; 2016 Aug 02; 100(16):7051-60. PubMed ID: 26960322
    [Abstract] [Full Text] [Related]

  • 38. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.
    Weinrauch L, Cawich F, Craig P, Sosa JX, el-On J.
    J Am Acad Dermatol; 1993 Sep 02; 29(3):443-6. PubMed ID: 8349861
    [Abstract] [Full Text] [Related]

  • 39. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J, Moreno E, Calvo A, Blanco L, Fernández-Rubio C, Sanmartín C, Nguewa P, Irache JM, Larrea E, Espuelas S.
    J Dermatol Sci; 2018 Oct 02; 92(1):78-88. PubMed ID: 30037731
    [Abstract] [Full Text] [Related]

  • 40. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1.
    Zur E.
    Int J Pharm Compd; 2019 Oct 02; 23(3):200-207. PubMed ID: 31085788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.